Puma Biotechnology (PBYI) Interest Coverage Ratio (2012 - 2026)
Puma Biotechnology (PBYI) posted Interest Coverage Ratio of 0.91 for Q1 2026, down 108.84% on a QoQ basis from 10.33 in Q4 2025, and down 322.28% year-over-year from 0.41 in Q1 2025.
Puma Biotechnology (PBYI) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Puma Biotechnology's Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 0.91 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 322.28% year-over-year to 0.91 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.03 (up 83.13% YoY) and the FY2025 annual result came in at 3.85, up 4165.25% from the prior year.
- Interest Coverage Ratio was 0.91 for Q1 2026 at Puma Biotechnology, down from 10.33 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 12.6 in Q3 2024 and bottomed at 1.47 in Q4 2022.
- A 5-year average of 1.9 and a median of 0.5 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio plunged 347.61% — and 2024, when it jumped 1323.89%.
- Puma Biotechnology's Interest Coverage Ratio stood at 1.47 in 2022, then soared by 318.39% to 3.21 in 2023, then gained by 4.88% to 3.37 in 2024, then jumped by 206.76% to 10.33 in 2025, then plunged by 108.84% to 0.91 in 2026.
- Business Quant data shows PBYI's Interest Coverage Ratio at 0.91 in Q1 2026, 10.33 in Q4 2025, and 0.99 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | -0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.91 |
| Dec 31, 2025 | 10.33 |
| Sep 30, 2025 | 0.99 |
| Jun 30, 2025 | 0.68 |
| Mar 31, 2025 | 0.41 |
| Dec 31, 2024 | 3.37 |
| Sep 30, 2024 | 12.60 |
| Jun 30, 2024 | -0.21 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | 3.21 |
| Sep 30, 2023 | 0.89 |
| Jun 30, 2023 | 0.50 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | -1.47 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 1.51 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | 0.59 |
| Sep 30, 2021 | 2.76 |
| Jun 30, 2021 | -0.61 |